Clinical Trials Directory

Trials / Completed

CompletedNCT04692168

Influence of Chemotherapy on Postural Control in Women With Cancer

Influence of Chemotherapy on Postural Control and Quality of Life in Women With Gynaecological Cancer: a Prospective Observational Study

Status
Completed
Phase
Study type
Observational
Enrollment
35 (actual)
Sponsor
Aline Reinmann · Academic / Other
Sex
Female
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to understand the strategies for adapting postural control in patients who have received chemotherapy treatment for gynaecological cancer.

Detailed description

Chemotherapy can cause many side effects, including peripheral neuropathies. Chemotherapy induced peripheral neuropathies (CIPN) are primarily sensory impairments that can alter the signals for somatosensory feedback and thus affect the postural control in the standing position. The objective of this study is to evaluate the impact of chemotherapy and peripheral neuropathies on postural control in the standing position. As balance maintenance is a complex construct involving different systems, this study will evaluate maintenance strategies during sensory disturbances in order to better understand post-chemotherapy coping strategies. These sensory disturbances concern vision (eyes closed) and the alteration of the somatosensory system (foam under the feet and vibration system). In addition, this study will evaluate balance in double task situations and dynamic stability. Given the consequent impact of chemotherapy and peripheral neuropathies on quality of life, a quality of life questionnaire will also be administered.

Conditions

Timeline

Start date
2020-10-07
Primary completion
2022-12-31
Completion
2022-12-31
First posted
2020-12-31
Last updated
2023-05-06

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT04692168. Inclusion in this directory is not an endorsement.